554
Views
14
CrossRef citations to date
0
Altmetric
Cardiovascular

Medium- to long-term persistence with non-vitamin-K oral anticoagulants in patients with atrial fibrillation: Australian experience

, , , &
Pages 1337-1341 | Received 24 Feb 2017, Accepted 18 Apr 2017, Published online: 10 May 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Darko Mitrovic, Richard Folkeringa, Nic Veeger & Eric van Roon. (2020) Reasons for discontinuation of novel oral anticoagulant therapy in patients with atrial fibrillation. Current Medical Research and Opinion 36:4, pages 547-553.
Read now

Articles from other publishers (13)

Adenike R Adelakun, Ricky D Turgeon, Mary A De Vera, Kimberlyn McGrail & Peter S Loewen. (2023) Oral anticoagulant switching in patients with atrial fibrillation: a scoping review. BMJ Open 13:4, pages e071907.
Crossref
Pablo Díez-Villanueva, Juan Cosín-Sales, Vanesa Roldán-Schilling, Vivencio Barrios, Diana Riba-Artés & Olga Gavín-Sebastián. (2023) Use of Direct Acting Oral Anticoagulants in Elderly Patients with Atrial Fibrillation: A Multicenter, Cross-Sectional Study in Spain. Journal of Clinical Medicine 12:3, pages 1224.
Crossref
Shahrzad Salmasi, Abdollah Safari, Anita Kapanen, Adenike Adelakun, Leanne Kwan, Jenny MacGillivray, Jason G. Andrade, Marc W. Deyell & Peter Loewen. (2022) Oral anticoagulant adherence and switching in patients with atrial fibrillation: A prospective observational study. Research in Social and Administrative Pharmacy 18:11, pages 3920-3928.
Crossref
Adane Teshome Kefale, Woldesellassie M. Bezabhe & Gregory M. Peterson. (2022) Oral Anticoagulant Discontinuation and Its Predictors in Patients with Atrial Fibrillation. Journal of Clinical Medicine 11:20, pages 6022.
Crossref
Anke C. Fender & Dobromir Dobrev. (2022) The temporal context of oral anticoagulation outcome in atrial fibrillation. IJC Heart & Vasculature 40, pages 101051.
Crossref
Elham Rahme, Richard Godin, Hacene Nedjar, Kaberi Dasgupta & Vicky Tagalakis. (2021) Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study. Thrombosis Research 203, pages 121-130.
Crossref
P.P. Olimpieri, A. Di Lenarda, F. Mammarella, L. Gozzo, A. Cirilli, M. Cuomo, M.M. Gulizia, F. Colivicchi, G. Murri, D. Gabrielli & F. Trotta. (2020) Non-vitamin K antagonist oral anticoagulation agents in patients with atrial fibrillation: Insights from Italian monitoring registries. IJC Heart & Vasculature 26, pages 100465.
Crossref
Andrea L. Schaffer, Michael O. Falster, David Brieger, Louisa R. Jorm, Andrew Wilson, Melanie Hay, Kira Leeb, Sallie Pearson & Arthur Nasis. (2019) Evidence‐Practice Gaps in Postdischarge Initiation With Oral Anticoagulants in Patients With Atrial Fibrillation. Journal of the American Heart Association 8:24.
Crossref
Nicole Lowres, Katrina Giskes, Charlotte Hespe & Ben Freedman. (2019) Reducing Stroke Risk in Atrial Fibrillation: Adherence to Guidelines Has Improved, but Patient Persistence with Anticoagulant Therapy Remains Suboptimal. Korean Circulation Journal 49:10, pages 883.
Crossref
Cia Connell & Garry L.R. Jennings. (2018) Pioneering Australia’s First Atrial Fibrillation Guidelines. Heart, Lung and Circulation 27:12, pages 1391-1393.
Crossref
David Brieger, John Amerena, John R Attia, Beata Bajorek, Kim H Chan, Cia Connell, Ben Freedman, Caleb Ferguson, Tanya Hall, Haris M Haqqani, Jeroen Hendriks, Charlotte M Hespe, Joseph Hung, Jonathan M Kalman, Prashanthan Sanders, John Worthington, Tristan Yan & Nicholas A Zwar. (2018) National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018. Medical Journal of Australia 209:8, pages 356-362.
Crossref
Simone Bonde Haastrup, Maja Hellfritzsch, Lotte Rasmussen, Anton Pottegård & Erik Lerkevang Grove. (2018) Use of Non-Vitamin K Antagonist Oral Anticoagulants 2008-2016: A Danish Nationwide Cohort Study. Basic & Clinical Pharmacology & Toxicology 123:4, pages 452-463.
Crossref
David Brieger, John Amerena, John Attia, Beata Bajorek, Kim H. Chan, Cia Connell, Ben Freedman, Caleb Ferguson, Tanya Hall, Haris Haqqani, Jeroen Hendriks, Charlotte Hespe, Joseph Hung, Jonathan M. Kalman, Prashanthan Sanders, John Worthington, Tristan D. Yan & Nicholas Zwar. (2018) National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018. Heart, Lung and Circulation 27:10, pages 1209-1266.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.